Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Service
3.3. Snippet by Source
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing demand for biologic drugs
4.1.2. Restraints
4.1.2.1. Strict regulatory requirements
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. SWOT Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Antibodies*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.2.1. Monoclonal Antibodies
7.2.2.2. Polyclonal Antibodies
7.2.2.3. Antibody Drug Conjugates
7.3. Vaccines
7.4. Cell and Gene Therapies
7.5. Recombinant Proteins
7.6. Others
8. By Service
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
8.1.2. Market Attractiveness Index, By Service
8.2. Process Development*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell development
8.4. cGMP Manufacturing
8.5. Analytical Testing
8.6. Others
9. By Source
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.1.2. Market Attractiveness Index, By Source
9.2. Mammalian*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.2.2.1. Animals
9.2.2.2. Human
9.3. Microorganisms
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Cardiovascular Diseases*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Infectious Diseases
10.4. Vaccine Development
10.5. Cell and Gene Therapy
10.6. Blood Related Product Development
10.7. Stem Cell Research
10.8. Oncology
10.9. Immunological Disorders
10.10. Others
11. By End-User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Pharmaceutical and Biotechnology Companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Pharmaceutical Companies
11.4. Biotechnology Companies
11.5. Research Organizations and Academia
11.6. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. AbbVie Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Thermo Fisher Scientific Inc.
14.3. Boehringer Ingelheim GmbH
14.4. Lonza Group Ag
14.5. Catalent Inc.
14.6. Sartorius Stedim Biotech S.A.
14.7. Charles River Laboratories International Inc.
14.8. WuXi Biologics Inc.
14.9. Samsung Biologics Co. Ltd.
14.10. Emergent BioSolutions Inc.
14.11. CordenPharma GmbH
14.12. Ajinomoto Bio-Pharma Services
14.13. Syngene International Limited
14.14. Rentschler Biopharma SE
14.15. Albany Molecular Research Inc.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us